KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: GBM Agile Update, page-58

  1. 4,523 Posts.
    lightbulb Created with Sketch. 110
    Did not meet the criteria to continue to second stage, sounds negative to a layman.
    Evaluation will continue for the first stage patients so still hope here.
    Readout in 2nd half 2023, so most likely the share price will be bottom bouncing for a whole year, and the result may still be underwhelming.

    The stock is dead for practical purposes.

    Revisit in 12 months time.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.